Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.
No abstract is available for this record.
Bibliographic context
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.
Related papers
PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-10Psychedelics: Threshold of a Therapeutic Revolution.Unknown journal · 2023-05-26Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a WorkshopNational Academies Press (US), Washington (DC) · 2022-08-31Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”Drug Science Policy and Law · 2026-05-31Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage PatternsJournal of Public Policy & Marketing · 2025-07-15From prohibited to prescribed: The rescheduling of MDMA and psilocybin in AustraliaDrug Science Policy and Law · 2022-12-31Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.Substance Abuse Treatment Prevention and Policy · 2022-05-13Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-06-12